Applied Therapeutics, Inc. (APLT) Misses Q1 EPS by 52c
Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q1 EPS of ($0.67), $0.52 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.
